Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.48M | -26.62M | -35.18M | -29.38M | -114.47M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 279.00K | 0.00 | 0.00 | 627.00K | 627.00K |
| Total Other Non-Cash Items | 3.98M | 23.75M | 30.72M | 21.83M | 103.23M |
| Change in Net Operating Assets | 1.04M | 346.00K | 1.69M | -349.00K | 1.18M |
| Cash from Operations | -4.18M | -2.53M | -2.77M | -7.26M | -9.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3.40M | 1.64M | 740.00K | 7.48M | 8.91M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -1.55M | -2.10M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 14.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.00K | 99.00K | 1.54M | -10.67M |
| Cash from Financing | 3.40M | 1.74M | 839.00K | 7.48M | 10.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -780.00K | -791.00K | -1.93M | 213.00K | 970.00K |